Log in

Relevant bibliographies by topics / Pharmacien clinicien

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers

Academic literature on the topic 'Pharmacien clinicien'

Author: Grafiati

Published: 4 June 2021

Last updated: 4 May 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Pharmacien clinicien.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Pharmacien clinicien"

1

Xuereb, Fabien, and Sonia Prot-Labarthe. "Le Pharmacien Clinicien : bientôt la première bougie !" Le Pharmacien Clinicien 57, no. 4 (December 2022): 297–98. http://dx.doi.org/10.1016/j.phacli.2022.10.742.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Bendoucha, F., M. Charles, and M. Rhalimi. "Évaluation de la fragilité par le pharmacien clinicien." Le Pharmacien Hospitalier et Clinicien 48, no. 4 (December 2013): 277. http://dx.doi.org/10.1016/j.phclin.2013.10.051.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Mille, F., J. E. Fontan, and P. Bedouch. "Quelles Apps utiles sur mon smartphone de pharmacien clinicien ?" Annales Pharmaceutiques Françaises 75, no. 4 (July 2017): 309–17. http://dx.doi.org/10.1016/j.pharma.2017.02.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Leroux, A., A. Guérin, F. Lagrange, and J. F. Bussières. "Rôle et retombées du pharmacien : analyse descriptive des publications du Pharmacien Hospitalier et Clinicien depuis 1990." Le Pharmacien Hospitalier et Clinicien 50, no. 3 (September 2015): 276–88. http://dx.doi.org/10.1016/j.phclin.2014.12.005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Breuker, C., L. Di Trapani, S. Boix, A. J. Romain, M. Picandet, A. Avignon, S. Hansel-Esteller, and A. Sultan. "P312 Pharmacien clinicien, un atout majeur dans un service d’endocrinologie-nutrition." Diabetes & Metabolism 41 (March 2015): A112. http://dx.doi.org/10.1016/s1262-3636(15)30425-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Dray, J., A. Soubieux-Bourbon, C. Chenailler, F. Dujardin, and R. Varin. "Revue de littérature sur l’impact économique du pharmacien clinicien en orthopédie." Le Pharmacien Clinicien 57, no. 4 (December 2022): e190-e191. http://dx.doi.org/10.1016/j.phacli.2022.10.719.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Philippi, C., S. Micou, N. Allaire, A. S. Guirriec, M. Faugier, M. Gaume, P. Ly, C. Berge-Bouchara, and C. Airiau. "Opportunités d’implication du pharmacien clinicien dans le parcours de chirurgie bariatrique." Le Pharmacien Clinicien 57, no. 4 (December 2022): e188-e189. http://dx.doi.org/10.1016/j.phacli.2022.10.715.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Coquet, E., J. Coutet, C. Renzullo, and J. F. Penaud. "Patients traites par digitalique ou antiépileptique : une priorité pour le pharmacien clinicien ?" Le Pharmacien Hospitalier et Clinicien 47, no. 1 (March 2012): 58. http://dx.doi.org/10.1016/j.phclin.2011.12.247.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Jean-Bart, E., R. Faure, S. Omrani, T. Guilli, C. Roubaud, P. Krolak-Salmon, and C. Mouchoux. "Place du pharmacien clinicien dans l’optimisation thérapeutique en hôpital de jour gériatrique." Annales Pharmaceutiques Françaises 72, no. 3 (May 2014): 184–93. http://dx.doi.org/10.1016/j.pharma.2013.12.008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Muller, K., T. Dantin, L. H. Heng, M. Orloff, M. L. Duchene, M. Milano, T. Collomp, et al. "Sécurisation des médicaments à haut risque : quels rôles pour le pharmacien clinicien ?" Le Pharmacien Clinicien 57, no. 4 (December 2022): e108-e109. http://dx.doi.org/10.1016/j.phacli.2022.10.562.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Pharmacien clinicien"

1

Mouchnino, Anne. "Rôle du pharmacien clinicien dans l'éducation et l'information du pharmacien d'officine sur le diabète." Paris 5, 1995. http://www.theses.fr/1995PA05P054.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Baudrant-Boga, Magalie. "Penser autrement le comportement d'adhésion du patient au traitement médicamenteux : modélisation d'une intervention éducative ciblant le patient et ses médicaments dans le but de développer des compétences mobilisables au quotidien : application aux patients diabétiques de type 2." Phd thesis, Grenoble 1, 2009. http://www.theses.fr/2009GRE10156.

Full text

Abstract:

L'ensemble des études évaluant l'observance médicamenteuse montre un taux moyen de 50%. Dans une première partie, nous décrivons l'évolution des définitions de ce phénomène puis les méthodes d'évaluation disponibles. L'indicateur de résultat défini par « l'adhérence médicamenteuse » se voit remplacer par un indicateur de processus �� l'adhésion au traitement médicamenteux ». Dans une seconde partie, nous décrivons les différents facteurs pouvant influencer cette adhésion, catégorisés selon 5 dimensions : maladie, traitement médicamenteux, facteurs démographiques et socio-économiques, patient et/ou entourage et système de soins. Leurs impacts sur cette adhésion sont décrits et les modèles explicatifs sous-jacents explicités. En troisième partie, nous décrivons, en regard des 5 dimensions citées, les différentes stratégies d'interventions proposées, issues de la littérature (actions pratiques simples, interventions de type éducatives et/ou motivationnelles). De cette analyse, nous avons identifié 5 leviers d'actions potentiels. Un modèle d'intervention éducative intégrant ces leviers est proposé (application auprès de patients diabétiques de type 2). Cette adhésion sera favorisée en regard de 5 dimensions: 1. Compétences d'autogestion mobilisables au quotidien vis-à-vis des médicaments; 2. Sentiment d'efficacité personnelle; 3. Motivation dans la gestion au quotidien des médicaments; 4. Mobilisation des ressources du système de soins; 5. Participation active du patient aux décisions thérapeutiques. L'intersection des 3 mondes, patient, soignant, éducateur, autour du médicament permettra de négocier une feuille de route menant vers l'adhésion au traitement médicamenteux
All studies evaluating medication compliance show an average rate of 50%. Indeed, the definitions of this phenomenon are fluctuating and the issue of assessment methods is major. "Medication compliance" as a performance indicator, should be replaced by a process indicator “medication adherence”, which determinants can be explored to understand the origins of this behaviour. Many factors influencing this adherence were identified and categorized according to 5 dimensions: illness, medication, demographic and socio-economic, patient and/or environment and health care. Their impact on adherence is described. Starting from these factors, intervention strategies are proposed (simple practical actions, educational and/or motivational interventions). Therapeutic education approach is described. We propose a synthesis of the interventions described in the literature categorized in the 5 dimensions listed. These data provide conflicting results (positive trend on the medication adherence without systematic clinical effect). We finally define five potential levels of action: A model of educational intervention to encourage and reinforce medication adherence is proposed (and applied to patients with type 2 diabetes). This adherence will be promoted in terms of: 1. Self-management skills on a daily basis with drugs ; 2. Self-efficacy ; 3. Motivation in the daily management of drugs; 4. Mobilisation of health care facilities; 5. Shared decision-making abilities. The intersection of the 3 worlds, patients, health professionals educators around the drugs will participate in promoting adherence to drugs

APA, Harvard, Vancouver, ISO, and other styles

3

Baudrant-Boga, Magalie. "Penser autrement le comportement d'adhésion du patient au traitement médicamenteux : modélisation d'une intervention éducative ciblant le patient et ses médicaments dans le but de développer des compétences mobilisables au quotidien - Application aux patients diabétiques de type 2 -." Phd thesis, 2009. http://tel.archives-ouvertes.fr/tel-00488730.

Full text

Abstract:

L'ensemble des études évaluant l'observance médicamenteuse montre un taux moyen de 50%. Dans une première partie, nous décrivons l'évolution des définitions de ce phénomène puis les méthodes d'évaluation disponibles. L'indicateur de résultat défini par " l'adhérence médicamenteuse " se voit remplacer par un indicateur de processus " l'adhésion au traitement médicamenteux ". Dans une seconde partie, nous décrivons les différents facteurs pouvant influencer cette adhésion, catégorisés selon 5 dimensions : maladie, traitement médicamenteux, facteurs démographiques et socio-économiques, patient et/ou entourage et système de soins. Leurs impacts sur cette adhésion sont décrits et les modèles explicatifs sous-jacents explicités. En troisième partie, nous décrivons, en regard des 5 dimensions citées, les différentes stratégies d'interventions proposées, issues de la littérature (actions pratiques simples, interventions de type éducatives et/ou motivationnelles). De cette analyse, nous avons identifié 5 leviers d'actions potentiels. Un modèle d'intervention éducative intégrant ces leviers est proposé (application auprès de patients diabétiques de type 2). Cette adhésion sera favorisée en regard de 5 dimensions: 1.compétences d'autogestion mobilisables au quotidien vis-à-vis des médicaments; 2.sentiment d'efficacité personnelle; 3.motivation dans la gestion au quotidien des médicaments; 4.mobilisation des ressources du système de soins; 5.participation active du patient aux décisions thérapeutiques. L'intersection des 3 mondes, patient, soignant, éducateur, autour du médicament permettra de négocier une feuille de route menant vers l'adhésion au traitement médicamenteux.

APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Pharmacien clinicien"

1

Mautrait. Guide pratique des dermatoses et soins courants à l'officine: À l'usage des pharmaciens, des préparateurs et des médecins cliniciens. Editions Masson, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Emmett, Stevan R., Nicola Hill, and Federico Dajas-Bailador. Clinical Pharmacology for Prescribing. Oxford University Press, 2019. http://dx.doi.org/10.1093/oso/9780199694938.001.0001.

Full text

Abstract:

Clinical Pharmacology for Prescribing explains how drugs work and why they should be prescribed for common medical conditions. Linking disease processes to pharmacological interventions, this guide gives a sound basis for evidence based prescribing. Written for medical students, trainee doctors and non-medical prescribers, it addresses all aspects of practical pharmacology, explaining drug classes, their mechanisms and effects on the body. Ultimately its focus is on clinical use, so that safe prescribing decisions are based on sound understanding of science - why and how drugs work to treat common conditions. Every chapter provides clear linkages between pathophysiology of disease and drug mechanisms, highlighted in original illustrations that bring together drug mechanisms, pathways and their place in medical management. Unwanted effects, drug interactions and prescribing warnings are emphasised to help the reader become aware of critical issues in prescribing. This resource also addresses how to prescribe for vulnerable patient groups and provokes deep understanding for patient safety. Written by a Practicing Pharmaceutical Physician with a D.Phil in Pharmacology, an Assistant Professor with the Faculty of Medicine and Health Sciences and a Senior hospital-based Clinical Pharmacist. The textbook has been extensively reviewed by practicing clinicians such that this new resource exemplifies the skills and knowledge needed for practical, legal and safe clinical prescribing.

APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Pharmacien clinicien"

1

Doran, Christopher M. "The pharmacist, the pharmaceutical industry and the clinician." In Prescribing Mental Health Medication, 473–77. 3rd ed. London: Routledge, 2021. http://dx.doi.org/10.4324/9781003030430-34.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

"The pharmacist, the pharmaceutical industry and the clinician." In Prescribing Mental Health Medication, 502–6. Routledge, 2013. http://dx.doi.org/10.4324/9780203111826-38.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

"The pharmacist, the pharmaceutical industry and the clinician." In Prescribing Mental Health Medication, 391–95. Routledge, 2005. http://dx.doi.org/10.4324/9780203987704-38.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Shaw, Ryan J., Kristin Montgomery, Christopher Fiander, Kelcie Bullock, Ryan Craig, Gina Pennington, and Matthew J. Crowley. "Mobile Monitoring-Enabled Telehealth for Patients with Complex Chronic Illnesses." In Studies in Health Technology and Informatics. IOS Press, 2024. http://dx.doi.org/10.3233/shti230954.

Full text

Abstract:

Telehealth has the potential to improve management of poorly controlled chronic diseases relative to clinic-based care alone. Mobile monitoring-enabled technologies could enhance telehealth for chronic illness care. Implementation in practice settings would rely on automated integration of data into the electronic health record (EHR). We describe the integration and visualization of data from four remote monitoring devices into the EHR that is coupled with the evaluation of an evidence-based nurse and pharmacist-led telehealth care model for patients with uncontrolled diabetes and hypertension. Using this new pragmatic infrastructure, clinicians use the EHR to prescribe for patients a suite of devices. Alerts are placed upon the data that notify a clinician when values go above or below set thresholds. These data are visualized in the clinical record and clinicians use the EHR as a tool for efficiently delivering and documenting patient telehealth encounters.

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Pharmacien clinicien"

1

Beristain Aramendi, I., A. Ros, J. Boo, T. González, J. Landa, A. Eceiza, C. Bachiller, MJ Gayán, and G. Lizeaga. "4CPS-187 Pharmacist–clinician collaborative study for prospective identification of drug interactions in HIV patients." In 26th EAHP Congress, Hospital pharmacists – changing roles in a changing world, 23–25 March 2022. British Medical Journal Publishing Group, 2022. http://dx.doi.org/10.1136/ejhpharm-2022-eahp.190.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Abdulrhim, Sara Hamdi, Sownd Sankaralingam, and Mohamed Izham. "The Impact of Pharmacist Care on Diabetes Outcomes in Primary Care Settings: An Umbrella Review of Systematic Reviews." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2020. http://dx.doi.org/10.29117/quarfe.2020.0174.

Full text

Abstract:

Objective: To systematically review published systematic reviews (SRs) examining the impact of pharmacist interventions in multidisciplinary diabetes care teams on diabetes-related clinical, humanistic, and economic outcomes in primary care settings. Methods: PubMed, EMBASE, Scopus, Database of Abstracts of Reviews of Effects, Cochrane Library, Joanna Briggs Institute (JBI) Database, Google Scholar, and PROSPERO were searched from inception to 2018. Studies published in English evaluating the effect of pharmacist interventions on diabetes outcomes were included. Two independent reviewers were involved in the screening of titles and abstracts, selection of studies, and methodological quality assessment. Results: Seven SRs were included in the study. Three of them included only randomized controlled trials, while the rest involved other study designs. Educational interventions by clinical pharmacists within the healthcare team were the most common types of interventions reported across all SRs. Pharmacist’s interventions compared to usual care resulted in favorable significant improvements in hemoglobin A1c (HbA1c), fasting blood glucose, blood pressure, body mass index, total cholesterol, lowdensity lipoprotein, high-density lipoprotein and triglycerides in more than 50% of the SRs. Improvement in HbA1c was the mostly reported clinical outcome of pharmacist intervention in the literature (reported in six SRs). Pharmacist’s interventions led to significant cost-saving ($8–$85,000 per person per year), cost-utility, and cost-benefit (benefit-to-cost ratio range from 1:1 to 8.5:1) versus usual care. Pharmacist’s interventions improved patients’ quality of life (QoL) in three SRs; however, no conclusion can be drawn due to the use of diverse QoL assessment tools. Conclusion: Most SRs support the benefit of pharmacist care on diabetes-related clinical, humanistic, and economic outcomes in primary care settings. Improvements in diabetes outcomes can significantly reduce the burden of diabetes on the healthcare system. Hence, the incorporation of pharmacists into multidisciplinary diabetes care teams is beneficial and should be strongly considered by clinicians and health policymakers.

APA, Harvard, Vancouver, ISO, and other styles

3

Aiello, M., V. Wilkie, and E. Hughes. "6ER-025 Pharmacist clinicians in hospitals – transforming the workforce with new models of patient care." In Abstract Book, 23rd EAHP Congress, 21st–23rd March 2018, Gothenburg, Sweden. British Medical Journal Publishing Group, 2018. http://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.517.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!